Literature DB >> 22861166

Asymmetric time-dependent activation of right central amygdala neurones in rats with peripheral neuropathy and pregabalin modulation.

Leonor Gonçalves1, Anthony H Dickenson.   

Abstract

Neuropathic pain (NP) often presents with comorbidities, including depression and anxiety. The amygdala is involved in the processing of mood disorders, fear, and the emotional-affective components of pain. Hemispheric lateralization of pain processing in the amygdala has recently been brought to light because, independently of the side of the peripheral injury, the right central nucleus of the amygdala (CeA) showed higher neuronal activity than the left in models of inflammatory pain. Although the CeA has been called the 'nociceptive amygdala', because of its high content of nociceptive neurones, little is known about changes in its neuronal function in vivo, under NP conditions. Herein, we quantified CeA spontaneous and evoked activity in rats subjected to spinal nerve ligation (SNL), under isoflurane anaesthesia, following application of mechanical and thermal stimuli to widespread body areas. We found that spontaneous and stimulus-evoked neuronal activity was higher in the left CeA at 2 and 6 days after SNL induction and declined afterwards, whereas activity in the right CeA became dominant at 14 days after surgery, independently of the side of surgery. We also observed that systemic injection of pregabalin, which is widely used in patients with NP, reduced CeA spontaneous and stimulus-evoked neuronal activity. Overall, we observed that peripheral nerve injury produced asymmetric plasticity in ongoing and evoked activity in the left and right CeA. Remarkably, at 14 days after SNL induction, enhanced evoked activity in the right CeA persisted compared to short-term increases in activity in the left CeA. The plasticity found in ongoing and evoked activity was inhibited by pregabalin.
© 2012 The Authors. European Journal of Neuroscience © 2012 Federation of European Neuroscience Societies and Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22861166     DOI: 10.1111/j.1460-9568.2012.08235.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  47 in total

Review 1.  Amygdala pain mechanisms.

Authors:  Volker Neugebauer
Journal:  Handb Exp Pharmacol       Date:  2015

2.  CB1 augments mGluR5 function in medial prefrontal cortical neurons to inhibit amygdala hyperactivity in an arthritis pain model.

Authors:  Guangchen Ji; Volker Neugebauer
Journal:  Eur J Neurosci       Date:  2014-02       Impact factor: 3.386

3.  5-HT2C Receptor Knockdown in the Amygdala Inhibits Neuropathic-Pain-Related Plasticity and Behaviors.

Authors:  Guangchen Ji; Wei Zhang; Lenin Mahimainathan; Madhusudhanan Narasimhan; Takaki Kiritoshi; Xiuzhen Fan; Jigong Wang; Thomas A Green; Volker Neugebauer
Journal:  J Neurosci       Date:  2016-12-23       Impact factor: 6.167

4.  Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention.

Authors:  Jennifer Y Xie; Milena De Felice; Caroline M Kopruszinski; Nathan Eyde; Justin LaVigne; Bethany Remeniuk; Pablo Hernandez; Xu Yue; Naomi Goshima; Michael Ossipov; Tamara King; John M Streicher; Edita Navratilova; David Dodick; Hugh Rosen; Ed Roberts; Frank Porreca
Journal:  Cephalalgia       Date:  2017-04-04       Impact factor: 6.292

5.  Nerve injury alters restraint-induced activation of the basolateral amygdala in male rats.

Authors:  James W M Kang; David Mor; Kevin A Keay
Journal:  Brain Struct Funct       Date:  2021-02-13       Impact factor: 3.270

6.  Reversal of peripheral nerve injury-induced neuropathic pain and cognitive dysfunction via genetic and tomivosertib targeting of MNK.

Authors:  Stephanie Shiers; Juliet Mwirigi; Grishma Pradhan; Moeno Kume; Bryan Black; Paulino Barragan-Iglesias; Jamie K Moy; Gregory Dussor; Joseph J Pancrazio; Sven Kroener; Theodore J Price
Journal:  Neuropsychopharmacology       Date:  2019-10-07       Impact factor: 7.853

7.  Small conductance calcium activated potassium (SK) channel dependent and independent effects of riluzole on neuropathic pain-related amygdala activity and behaviors in rats.

Authors:  Jeremy M Thompson; Vadim Yakhnitsa; Guangchen Ji; Volker Neugebauer
Journal:  Neuropharmacology       Date:  2018-06-13       Impact factor: 5.250

8.  A Neural Circuit from Thalamic Paraventricular Nucleus to Central Amygdala for the Facilitation of Neuropathic Pain.

Authors:  Shao-Hua Liang; Wen-Jun Zhao; Jun-Bin Yin; Ying-Biao Chen; Jia-Ni Li; Ban Feng; Ya-Cheng Lu; Jian Wang; Yu-Lin Dong; Yun-Qing Li
Journal:  J Neurosci       Date:  2020-09-21       Impact factor: 6.167

9.  The central amygdala to periaqueductal gray pathway comprises intrinsically distinct neurons differentially affected in a model of inflammatory pain.

Authors:  Jun-Nan Li; Patrick L Sheets
Journal:  J Physiol       Date:  2018-11-02       Impact factor: 5.182

Review 10.  Amygdala, neuropeptides, and chronic pain-related affective behaviors.

Authors:  Volker Neugebauer; Mariacristina Mazzitelli; Bryce Cragg; Guangchen Ji; Edita Navratilova; Frank Porreca
Journal:  Neuropharmacology       Date:  2020-03-15       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.